CN111978466B - Preparation method of methadone molecular imprinting film with one-dimensional photonic crystal structure - Google Patents
Preparation method of methadone molecular imprinting film with one-dimensional photonic crystal structure Download PDFInfo
- Publication number
- CN111978466B CN111978466B CN202010757445.XA CN202010757445A CN111978466B CN 111978466 B CN111978466 B CN 111978466B CN 202010757445 A CN202010757445 A CN 202010757445A CN 111978466 B CN111978466 B CN 111978466B
- Authority
- CN
- China
- Prior art keywords
- methadone
- photonic crystal
- dimensional photonic
- crystal structure
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 title claims abstract description 45
- 229960001797 methadone Drugs 0.000 title claims abstract description 44
- 239000004038 photonic crystal Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002243 precursor Substances 0.000 claims abstract description 18
- 229920000344 molecularly imprinted polymer Polymers 0.000 claims abstract description 7
- 229920006254 polymer film Polymers 0.000 claims abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- 239000012528 membrane Substances 0.000 claims description 16
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- AOIDYWIUVADOPM-UHFFFAOYSA-N 2-hydroxyethyl 2,3-dimethylbut-2-enoate Chemical compound CC(C)=C(C)C(=O)OCCO AOIDYWIUVADOPM-UHFFFAOYSA-N 0.000 claims description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 3
- 238000001514 detection method Methods 0.000 abstract description 7
- 230000003993 interaction Effects 0.000 abstract description 3
- 230000000007 visual effect Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 description 7
- 238000002310 reflectometry Methods 0.000 description 5
- 238000010828 elution Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920005597 polymer membrane Polymers 0.000 description 2
- 238000000985 reflectance spectrum Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000002756 mu opiate receptor agonist Substances 0.000 description 1
- 229940126487 mu opioid receptor agonist Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/56—Acrylamide; Methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/042—Elimination of an organic solid phase
- C08J2201/0424—Elimination of an organic solid phase containing halogen, nitrogen, sulphur or phosphorus atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Materials Engineering (AREA)
- Plasma & Fusion (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
The invention relates to a preparation method of a methadone molecular imprinting film with a one-dimensional photonic crystal structure, belonging to the technical field of photonic crystals and molecular imprinting. The technical scheme of the invention mainly comprises the following steps: preparing a methadone molecularly imprinted polymer precursor solution, preparing a polymer film based on a one-dimensional photonic crystal structure, and preparing a methadone molecularly imprinted film. The invention combines the photonic crystal and the molecular imprinting technology, and uses the color change generated by the interaction of the sensor film and the template molecule as a detection signal to realize the rapid visual detection of the molecularly imprinted polymer film, thereby being convenient and rapid to detect and greatly saving the time cost.
Description
Technical Field
The invention relates to the technical field of photonic crystals and molecular imprinting, in particular to a preparation method of a methadone molecular imprinting film with a one-dimensional photonic crystal structure.
Background
The molecular imprinting technology is also called molecular template technology, and is a process for forming a specific recognition site in a polymer through template induction. Where the target molecule and the polymer resemble a relationship of "key" and "lock", specific detection is achieved by this relationship of specific recognition. Photonic crystals are artificially produced materials with spatially periodic arrangements of dielectrics of different refractive indices. The one-dimensional photonic crystal is the simplest photonic crystal structure, and can generate structural color change when being stimulated by external environment.
Methadone is a mu opioid receptor agonist, can replace morphine to play an anesthetic role, can be matched with an stimulant poison to help a drug addict to get rid of poison dependence, but the improper dosage can cause great harm to human bodies, so that the control of the dosage of methadone during the matched treatment is the key of successful treatment, and has important significance for the determination of the content of methadone.
Disclosure of Invention
The invention provides a preparation method of a methadone molecular imprinting film with a one-dimensional photonic crystal structure. A one-dimensional photonic crystal template with the span of 761nm, the step pitch of 350nm and the height of 75nm is adopted, and the change of a reflection spectrum of a molecularly imprinted polymer film is measured by a spectrometer according to different responses of the molecularly imprinted polymer film to methadone by combining the photonic crystal and the molecularly imprinted technology, so that the methadone is measured.
The detection principle is as follows: when white incident light is irradiated on the sensor surface, the wavelength of the reflected light conforms to the grating equation: m λ ═ d (sin θ) 1 +θ D ) Where m is the number of diffraction orders, λ is the wavelength of diffracted light, θ 1 Is the light source incident angle; theta D Is the angle of reflection; d is the grating period.
When the molecular imprinting film is combined with methadone molecules, sample molecules enter the molecular imprinting cavity to generate structural change, the form on the film is changed, namely the height of the step is changed, the reflectivity of the reflection spectrum is macroscopically reflected to be changed, the change of the reflectivity is in a linear relation with the change of the concentration, and therefore the concentration of the sample molecules is detected.
The technical scheme of the invention is as follows: the preparation method of the methadone molecular imprinting film with the one-dimensional photonic crystal structure comprises the following steps:
(1) preparing a methadone molecularly imprinted polymer precursor solution: mixing 1.2mmol of template molecule methadone, 7.29mmol of methacrylic acid, 30.96mmol of acrylamide, 0.42mmol of cross-linking agent ethylene glycol dimethyl methacrylate, UV 11730.081mmol of photoinitiator and 2.4mL of methanol, stirring for 12h, uniformly mixing the solution, and deoxidizing with nitrogen for 5 minutes to obtain a precursor solution of the molecularly imprinted membrane;
(2) preparing a polymer film based on a one-dimensional photonic crystal structure: dripping 250mL of precursor solution on a clean glass sheet, covering a one-dimensional photonic crystal template on the precursor solution along one side of the precursor solution, then placing the precursor solution under an ultraviolet lamp to initiate polymerization for 2 hours, and removing the precursor solution after polymerization to obtain a polymer film;
(3) preparing a methadone molecular imprinting membrane: and ultrasonically eluting the imprinted molecules for 1 hour by using a methanol/acetic acid mixed solution to obtain the methadone molecular imprinted membrane with a one-dimensional photonic crystal structure.
Further, the one-dimensional photonic crystal template in the step (2) is a square template with the size of 20mm multiplied by 20 mm.
Further, the volume ratio of methanol to acetic acid in the step (3) is 9: 1.
The invention has the following beneficial effects:
(1) the photonic crystal molecularly imprinted membrane sensor is prepared by ultraviolet light initiated polymerization, so that the operation is simple and the preparation time is short; the size of the prepared sensor is only 20mm multiplied by 20mm, the size is small, and the sensor is convenient to carry; the photonic crystal is combined with the molecular imprinting technology, color change generated by interaction of the sensor membrane and the template molecule is used as a detection signal, and the molecular imprinting polymer membrane is detected quickly and visually, so that the detection is convenient and quick, and the time cost is greatly saved.
(2) The invention adopts a photonic crystal molecular imprinting method, develops a reliable detection method for detecting trace methadone, and is simple, convenient and time-saving compared with detection methods of large instruments such as liquid chromatography and the like.
(3) The invention utilizes the optical property of the photonic crystal structure to measure the reflection spectrum of the interaction between the sensor and the measured substance, and the measured spectrum has obvious change and is convenient to observe.
Drawings
FIG. 1 is a scanning electron microscope image of a one-dimensional photonic crystal template;
FIG. 2 shows reflectance spectra before and after elution with non-molecularly imprinted membrane (NMIP) and molecularly imprinted Membrane (MIP); wherein: a. NMIP, b, after elution, c, before elution.
Fig. 3 is a response of methadone molecular imprinted membrane to methadone solution;
wherein: a. water, b, 10 -9 mol/L,c、10 -8 mol/L,d、10 -7 mol/L,e、10 -6 mol/L,f、10 -5 mol/L。
Fig. 4 is a linear relationship graph of methadone and corresponding spectral reflectance at different concentrations.
Detailed Description
The technical solution of the present invention is further described below with reference to specific examples, but the present invention is not limited to the contents of the examples in any way. The test methods described in the examples are all conventional methods unless otherwise specified; unless otherwise specified, the reagents and biomaterials are commercially available.
Example 1 preparation of a methadone molecularly imprinted polymer precursor solution
(1) Adding template molecule methadone (1.2mmol), functional monomer methacrylic acid (7.29mmol), acrylamide (30.96mmol) and cross-linking agent ethylene glycol dimethyl methacrylate (0.42 mmol), photoinitiator UV 11730.081mmol into a round-bottom flask containing 2.4mL of methanol, mixing, and uniformly stirring at 25 ℃ for 12 h;
(2) after the solution is uniformly mixed, deoxidizing for 5min by using nitrogen, and obtaining the required polymer precursor solution;
example 2 preparation of a Polymer film based on a one-dimensional Photonic Crystal Structure
(1) Taking a clean glass sheet, dropwise adding 250 mu L of the prepared precursor solution on the glass sheet, and then slowly covering a 20 mm-20 mm prepared one-dimensional photonic crystal template with the span of 761nm and the height of 75nm on the solution along one side of the solution, wherein bubbles can not appear;
(2) and (3) placing the precursor solution under an ultraviolet lamp to initiate polymerization for 2 hours, and removing the precursor solution for later use after complete polymerization.
Example 3 preparation of a Memethadone molecular imprinted Membrane
(1) Preparing a solution of 10mL of methanol and acetic acid (9: 1), putting the polymerized photonic crystal polymer film into the solution, and carrying out ultrasonic washing;
(2) changing the eluent once every 15min for ultrasonic treatment, and changing for 4 times, wherein the total time is 1 h;
(3) after ultrasonic elution, the surface of the molecularly imprinted membrane is washed by a methanol solution to wash away excessive acetic acid.
Example 4 methadone assay
And (3) respectively placing the prepared methadone molecular imprinting films in methadone solutions with different concentrations for 5min, and immediately measuring the reflection spectrum of the methadone molecular imprinting films by using a spectrometer after the methadone molecular imprinting films are taken out. As shown in fig. 3, it can be seen that when the methadone molecular imprinted membrane was placed in the methadone solution, the reflectance of the polymer membrane gradually decreased as the measured concentration increased. From the measured reflectance spectrum, the sensor can detect a minimum concentration of 10 -9 mol/L. Meanwhile, the reflectivity and the concentration of the sensor film are subjected to linear fitting, the linear equation obtained by processing is-logC ═ R/3.39-15.13(R is the reflectivity at the maximum wavelength of the reflection spectrum, and C is the concentration of methadone), the linear correlation can reach 0.9929, and it can be seen that the negative logarithm of the molecularly imprinted film under different concentrations and the reflectivity at corresponding concentrations show good linear relation, as shown in FIG. 4, so the photonic crystal molecularly imprinted sensor film prepared by the method has good practical application value.
EXAMPLE 5 determination of methadone in samples
And (3) placing the methadone molecular imprinting film sensor in a urine sample to be detected which contains the methadone and is diluted for 5min, and immediately measuring the reflection spectrum of the sample by a spectrometer after the sample is taken out. According to the linear relation equation of the negative logarithm of the methadone concentration and the spectral reflectance, the methadone concentration in the measured sample is 5.26 multiplied by 10 -7 mol/L。
Example 6 measurement of interference rejection Capacity of methadone sensor
The invention also considers structural analogues of methadone, such as bisphenol A, diphenylamine and the like, finds that the structural analogues do not interfere with the measurement, and finds that the measurement is not interfered by inorganic salt more than 1000 times, and shows that the sensor has strong anti-interference capability.
Claims (2)
1. The preparation method of the methadone molecular imprinting membrane with the one-dimensional photonic crystal structure is characterized by comprising the following steps of:
(1) preparing a methadone molecularly imprinted polymer precursor solution: mixing 1.2mmol of template molecule methadone, 7.29mmol of methacrylic acid, 30.96mmol of acrylamide, 0.42mmol of cross-linking agent ethylene glycol dimethyl methacrylate, UV 11730.081mmol of photoinitiator and methanol, stirring for 12h, uniformly mixing the solution, and deoxidizing with nitrogen for 5 minutes to obtain a precursor solution of the molecularly imprinted membrane;
(2) preparing a polymer film based on a one-dimensional photonic crystal structure: dripping 250 mu L of precursor liquid on a clean glass sheet, covering a one-dimensional photonic crystal template which is prepared by 20mm multiplied by 20mm and has the span of 761nm and the height of 75nm on the precursor liquid along one side of the precursor liquid, then placing the template under an ultraviolet lamp to initiate polymerization for 2 hours, and removing the template after polymerization to obtain a polymer film;
(3) preparing a methadone molecular imprinting membrane: and ultrasonically eluting the imprinted molecules for 1 hour by using a methanol/acetic acid mixed solution to obtain the methadone molecular imprinted membrane with a one-dimensional photonic crystal structure.
2. The method for preparing a methadone molecular imprinted membrane having a one-dimensional photonic crystal structure according to claim 1, wherein the volume ratio of methanol to acetic acid in the step (3) is 9: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010757445.XA CN111978466B (en) | 2020-07-31 | 2020-07-31 | Preparation method of methadone molecular imprinting film with one-dimensional photonic crystal structure |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010757445.XA CN111978466B (en) | 2020-07-31 | 2020-07-31 | Preparation method of methadone molecular imprinting film with one-dimensional photonic crystal structure |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111978466A CN111978466A (en) | 2020-11-24 |
CN111978466B true CN111978466B (en) | 2022-08-16 |
Family
ID=73444790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010757445.XA Active CN111978466B (en) | 2020-07-31 | 2020-07-31 | Preparation method of methadone molecular imprinting film with one-dimensional photonic crystal structure |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111978466B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0605427D0 (en) * | 2006-03-17 | 2006-04-26 | Univ Cranfield | Materials For Binding Drugs Of Abuse |
EP2500314A1 (en) * | 2011-03-14 | 2012-09-19 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Photonic crystal sensor |
CN108003374B (en) * | 2017-12-01 | 2021-03-30 | 北京理工大学 | Molecular imprinting photonic crystal hydrogel film for rapidly detecting melamine |
-
2020
- 2020-07-31 CN CN202010757445.XA patent/CN111978466B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111978466A (en) | 2020-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jenkins et al. | Polymer-based lanthanide luminescent sensor for detection of the hydrolysis product of the nerve agent soman in water | |
US8085405B2 (en) | Detecting element, and target substance detecting device and method of detecting target substance using the same | |
US6749811B2 (en) | Molecularly imprinted polymer solution anion sensor | |
CN104198434B (en) | A kind of preparation method and applications of normal transmission type local plasmon resonance index sensor | |
CN111504941B (en) | Terahertz attenuated total reflection technology platform for unmarked evaluation of response characteristics of responsive hydrogel | |
CN111961159B (en) | Preparation method of polymer film with one-dimensional photonic crystal structure | |
Shaikh et al. | Molecularly imprinted surface plasmon resonance (SPR) based sensing of bisphenol A for its selective detection in aqueous systems | |
Mitchell | Spin-coated methacrylic acid copolymer thin films for covalent immobilization of small molecules on surface plasmon resonance substrates | |
Cao et al. | A sulfamethoxazole molecularly imprinted two-dimensional photonic crystal hydrogel sensor | |
Çakır et al. | Sensitive and selective detection of amitrole based on molecularly imprinted nanosensor | |
CN111978466B (en) | Preparation method of methadone molecular imprinting film with one-dimensional photonic crystal structure | |
CA2461026C (en) | Sensor for anions in solution based on a molecularly imprinted polymer | |
CN111978467B (en) | Application of one-dimensional photonic crystal sensor film | |
Dong et al. | A novel polymerization of ultrathin sensitive imprinted film on surface plasmon resonance sensor | |
AU2002356815A1 (en) | Molecularly imprinted polymer solution anion sensor | |
Zhang et al. | Development of molecularly imprinted photonic polymers for sensing of sulfonamides in egg white | |
Zheng et al. | Levofloxacin molecularly imprinted two dimensional photonic crystal hydrogel sensor | |
CN107501591B (en) | Preparation and application of bisphenol A molecularly imprinted polymer membrane | |
CN111982833B (en) | Detection method of caffeine molecules | |
JP2000121551A (en) | Concentration measuring device | |
RU2715478C1 (en) | Method of determining concentration of lead (ii) in aqueous samples | |
Kongswang et al. | A Compact, Low-Cost Optical Sensor for Progesterone Detection using Molecularly Imprinted Polymer | |
CN107340243B (en) | β -cyclodextrin modified holographic sensor method for quantitatively analyzing ibuprofen in biological sample | |
US20040253633A1 (en) | Raman techniques for detecting molecular interactions in molecularly imprinted polymers | |
AU2021100488A4 (en) | METHOD FOR QUANTITATIVELY ANALYZING IBUPROFEN IN BIOLOGICAL SAMPLE USING β-CYCLODEXTRIN-MODIFIED HOLOGRAPHIC SENSOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |